• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Viking Thera (NQ: VKTX )

    50.77 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 936
    Open 50.77
    Bid (Size) 51.15 (1)
    Ask (Size) 51.30 (1)
    Prev. Close 50.77
    Today's Range 50.77 - 50.77
    52wk Range 8.280 - 99.41
    Shares Outstanding 99,581,693
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Better Growth Stock: Archer Aviation or Viking Therapeutics?
    Which one of these potential disruptors is the better buy? 
    Via The Motley Fool
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga

    Performance

    YTD
    +177.74%
    +177.74%
    1 Month
    -22.32%
    -22.32%
    3 Month
    -38.09%
    -38.09%
    6 Month
    +163.47%
    +163.47%
    1 Year
    +227.34%
    +227.34%

    More News

    Read More
    Viking Therapeutics Unusual Options Activity For June 25
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    $100 Invested In This Stock 5 Years Ago Would Be Worth $600 Today
    Via Benzinga
    Viking Therapeutics Unusual Options Activity For June 12
    Via Benzinga
    Looking At Viking Therapeutics's Recent Unusual Options Activity
    Via Benzinga
    The Best Biotech Stock to Invest $1,000 in Right Now
    Via The Motley Fool
    3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
    Via The Motley Fool
    2 Growth Stocks Wall Street Analysts Think Can Soar by at Least 80%
    Via The Motley Fool
    Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It
    Via The Motley Fool
    Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug
    Via The Motley Fool
    3 Stocks Under $10 Set to Quadruple by 2025: June Edition
    Via InvestorPlace
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    3 Stocks to Buy if You Want to Turn Your $1,000 into $10,000 Within 2 Years
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    3 Stocks Quietly Preparing for a 10X Surge: June Edition
    Via InvestorPlace
    Skye Bioscience Pivots To Obesity After Glaucoma Flop; Shares Plummet
    Via Investor's Business Daily
    Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
    Via The Motley Fool
    This High-Flying Stock Just Announced More Good News: Time to Buy?
    Via The Motley Fool
    Profiting from the Crowd: 3 Stocks Set to Surge on Retail Investor Enthusiasm
    Via InvestorPlace
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review
    Via Investor's Business Daily
    Topics Stocks
    Exposures US Equities
    The 3 Most Undervalued Pharma Stocks to Buy in June 2024
    Via InvestorPlace
    Topics Economy
    Exposures Economy
    Is Viking Therapeutics Stock a Buy on the Dip?
    Via The Motley Fool
    What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.